NCT06663800

Brief Summary

Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare. This research fosters a patient-centered approach, enhancing cardio respiratory function. Patient education on these practices can empower individuals, actively contributing to their recovery and overall well-being.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

October 28, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2025

Completed
Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

2 months

First QC Date

October 23, 2024

Last Update Submit

October 28, 2024

Conditions

Keywords

Ujjayi ParanyamaCoronary artery bypass graftingPulmonary Function

Outcome Measures

Primary Outcomes (2)

  • Borg dyspnea

    (Modified CR-10 is used to assess the degree of dyspnea, rated from 0 to 10. Zero means nothing at all, 0.5=extremely slight, 1=very slight, 2=slight, 3=moderate, 4=somewhat severe, 5=severe, 7=very severe, 9=extremely severe (almost maximal)

    5days

  • PFT

    Spirometer is simple test used to help diagnose and monitor certain lung conditions by measuring how much air you can breathe out in one forced breathe. Which is a small machine attached by a cable to a mouthpiece. This spirometer yielded generally reproducible results that were generally valid compared to laboratory-based spirometry. The use of this handheld spirometer in clinical, occupational, and research settings seems justified

    5days

Secondary Outcomes (1)

  • Cardiac monitors

    5days

Study Arms (2)

arm:1 Pranayama

EXPERIMENTAL

Arm:1 Additional effects of Ujjayi Pranayama

Other: Ujjayi Paranayama

arm: 2 (standard protocol)

OTHER

Arm:2 (standard protocol)

Other: Standard Protocol

Interventions

Inhale or breathe in slowly while taking a deep, prolonged breath through both nostrils. As you inhale, attempt to tighten your throat and feel the air in your throat. Air should not come into contact with the interior of the nose. When air enters the throat, an odd sound is made. Allow the breath to be loose and easy while you slightly tighten the back of your throat and hiss lightly as you breathe in and out. The sound isn't forced, but it should be loud enough for someone to hear you if they were close. Now close your right nostril and release the breath through your left. As you exhale, try making the sound HHHHHAAAA

arm:1 Pranayama

Control Group will perform Deep Breathing Adhering to a FITT model protocol, with a frequency of 5 days. Intensity set at 8 repetitions, duration range from 10 to 15 minutes

arm: 2 (standard protocol)

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants who have 1st post op Day
  • Hemodynamically stable \& well oriented patient
  • Extubated Patient
  • Voluntary based patients
  • After approval of surgeon CABG patient were recruited
  • Tachypnea

You may not qualify if:

  • Hemodynamically unstable,
  • Uncontrolled Hypertension,
  • MSK disease,
  • Any previous history of tuberculosis,
  • Neurological disease ,
  • Acute exacerbation of COAD \& Asthma Attack,
  • Any trauma, anxiety or Rib fracture case ,
  • During surgery complaint of graft failure ,
  • Unwilling to participate ,
  • Postural Hypotension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Railway general hospital

Rawalpindi, Punjab Province, 46060, Pakistan

Location

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

AIEOP acute lymphoblastic leukemia protocol

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Maria Razzaq, MSCPPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maria Razzaq, MSCPPT

CONTACT

Iqbal Tariq, MSCPPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2024

First Posted

October 29, 2024

Study Start

October 28, 2024

Primary Completion

December 15, 2024

Study Completion

January 18, 2025

Last Updated

October 29, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

maintaining confidentiality

Locations